홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.8
  1. 홈
  2. /화합물

1,2,4,6,9-Pentachlorodibenzo-P-dioxin

HCID 54846
노트반응
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
82291-36-9
표준 SMILES
Clc1cc(Cl)c2c(c1Cl)Oc1c(Cl)ccc(Cl)c1O2
InChIKey
GNQVSAMSAKZLKE-UHFFFAOYSA-N
분자식
C12H3Cl5O2
평균 분자량
356.4 g/mol
단동위원소 질량
353.857568

개요

1,2,4,6,9-Pentachlorodibenzo-p-dioxin is one of 75 chlorinated dibenzo-p-dioxin (CDD) congeners. CDDs are a class of manufactured chemicals that consist of dioxin skeletel structures with chlorine substituents. They are also persistent organic pollutants (POPs), thus their production is regulated in most areas. Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)

이름 및 식별자

우선 이름
1,2,4,6,9-Pentachlorodibenzo-P-dioxin
IUPAC
1,2,4,6,9-pentachlorodibenzo-p-dioxin
영어명
1,2,4,6,9-PCDD
분자식
C12H3Cl5O2
분자량
356.42

이름 및 동의어

1,2,4,6,9-Pentachlorodibenzo-p-dioxin82291-36-91,2,4,6,9-pentachlorooxanthreneUNII-76RG9UTM9B76RG9UTM9BPCDD 59Dibenzo(b,e)(1,4)dioxin, 1,2,4,6,9-pentachloro-Dibenzo-p-dioxin, 1,2,4,6,9-pentachloro1,2,4,6,9-PENTACHLORODIBENZODIOXINDTXSID30741071,2,4,6,9-PECDDRefChem:71487
이름 더 보기
1,2,4,6,9-PCDD1,2,4,6,9-Pentachlorodibenzo[1,4]dioxin1,2,4,6,9-Pentachlorodibenzo[b,e][1,4]dioxin
DTXCID3048285GNQVSAMSAKZLKE-UHFFFAOYSA-NNS00121662Q27266505

데이터베이스 식별자

CAS
82291-36-9
PubChem CID
54846
DTXSID
DTXSID3074107
UNII
76RG9UTM9B
Nikkaji
J372.966D

물성

구조 계산 물성

XLogP
6.2
극성 표면적
18.5 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
2
회전 가능 결합 수
0
무거운 원자 수
19
형식 전하
0
복잡도
344

실험 및 물리화학적 성질

LogP6.6

물리화학적 성질

Henry's Law Constant
1.3 · 1.3×100 mol/(m3Pa) at 25℃, Wang and Wong (2002)
EPA
1 · 1,2,4,6,9-Pentachlorodibenzo-p-dioxin (82291-36-9)

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 및 보호

Minimum Risk LevelAcute Oral: 0.0002 ug/kg/day (L134) Intermediate Oral: 0.00002 ug/kg/day (L134) Chronic Oral: 0.000001 ug/kg/day (L134)

독성 정보

TreatmentTreatment of CDD exposure may include washing the area of contact, GI decontamination, administering an IV, or forced alkaline diuresis. (L346)
Health Effects · 1건

Exposure to large amounts of CDDs causes chloracne, a severe skin disease with acne-like lesions that occur mainly on the face and upper body. CDDs may also cause liver damage and induce long-term alterations in glucose metabolism and subtle changes in hormonal levels. In addition, studies have shown that CDDs may disrupt the endocrine system and weaken the immune system, as well as cause reproductive damage and birth defects, central and peripheral nervous system pathology, thyroid disorders, endometriosis, and diabetes. (L177, L178)

Exposure RoutesOral (L177) ; inhalation(L177) ; dermal (L177)
Toxicity Summary · 1건

CDDs cause their toxic effects by binding to the aryl hydrocarbon receptor and subsequently altering the trascription of certain genes. The affinity for the Ah receptor depends on the structure of the specific CDD. The change in gene expression may result from the direct interaction of the Ah receptor and its heterodimer-forming partner, the aryl hydrocarbon receptor nuclear translocator, with gene regulatory elements or the initiation of a phosphorylation/dephosphorylation cascade that subsequently activates other transcription factors. The affected genes include several oncogenes, growth factors, receptors, hormones, and drug-metabolizing enzymes. The change in transcription/translation of these genes is believed to be the cause of most of the toxic effects of CDDs. (L177)

Signs and SymptomsIn addition to chloracne, CDD exposure causes skin rashes, discoloration, and excessive body hair. (L177)

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

CDDs are absorbed through oral, inhalation, and dermal routes of exposure. CDDs are carried in the plasma by serum lipids and lipoproteins, distributing mainly to the liver and adipose tissue. CDDs are very slowly metabolized by the microsomal monooxygenase system to polar metabolites that can undergo conjugation with glucuronic acid and glutathione. They may increase the rate of their own metabolism by inducing both phase I and phase II enzymes. The major routes of excretion of CDDs are the bile and the faeces, though smaller amounts are excreted in the urine and via lactation. (L177)

용도 및 제조

Uses · 1건

Dioxins occur as by-products from the manufacture of organochlorides, the bleaching of paper, chlorination by waste and drinking water treatment plants, municipal solid waste and industrial incinerators, and natural sources such as volcanoes and forest fires. (L177, L178)

공급사2 곳

上海稳同科技有限公司02151600108 13062666369 · [email protected]
青岛腾龙微波科技有限公司0532-83818797 17669478191 · [email protected]

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Carcinogen Classification3, not classifiable as to its carcinogenicity to humans. (L135)